ID
LinkedIn

Iraj Daizadeh PhD MBA

Global Head, Regulatory Affairs (GRA), Innovative Medicines

Greater Boston · 1 connection

Sun Pharmaceuticals

Not on Unlinked · Imported profile. Is this you? Claim it

About

Iraj Daizadeh, PhD, MBA, is the Global Head of Regulatory Affairs (GRA) for Development (Brands/Innovative Medicines/Biosimilars) at Sun Pharmaceuticals. His current work is to build a cross-discipline, worldwide regulatory and quality team suitable to support a mid-to-large pharmaceutical company portfolio comprised of inline (Ilumya, Leqselvi, Winlevi, Cequa, Odomzo, Yonza, Absorbica, Levulan, Xelpos, Sezaby, Unloxcyt) and pipeline of small and large molecule assets across rare (orphan) and common rheumatology/immunology, oncology, dermatology, gastrointestinal, ophthalmology, neurology, and internal medicine (e.g., obesity/T2D) indications. His team successfully led Sun’s first original global marketing authorization for an innovative medicine (Leqselvi), and business development/due diligence/alliance management efforts (e.g., Checkpoint Pharmaceutics, Checkpoint Therapeutics). Prior to Sun, at Takeda, he was the VP/Head, GRA, Rare Diseases (Genetics, Immunology and Hematology), where his team successfully led two original global marketing application approvals (Livtencity and Adzynma) and met various inline (Trintellix, Takhzyro, Vonvendi, Natpara, Advate, Adynovate) and pipel

Experience

Global Head, Regulatory Affairs (GRA), DevelopmentSUN PHARMA
Dec 2023
Vice President (Head), GRA, Rare Diseases (Genetic, Immunology, Hematology), Neuroscience and PolicyTakeda
Jan 2020 to Jan 2023
Global Regulatory Portfolio Leader (Head), GRA, Neuroscience and Internal Medicine (Cardiometabolic)Pfizer
Jan 2016 to Jan 2020
Global Program Regulatory Director, GRA, Respiratory/ImmunologyNovartis
Jan 2015 to Jan 2016
Global Regulatory Leader (Assoc. Director), GRA, Hematology (Rare Blood Disorders)Baxalta
Jan 2013 to Jan 2015
Managing Consultant: Regulatory Affairs, Quality, and ComplianceIBM
Jan 2007 to Jan 2008
Global Regulatory (Labeling) Leader (Sr. Mgr/Assoc. Director), GRA, Oncology/Immunology/NephrologyAmgen
Jan 2008 to Jan 2013
Global Regulatory (Strategic Planning and Operations) Leader (Sr. Mgr/AD), GRA, Cross-PortfolioAmgen
Jan 2004 to Jan 2007
(Independent) Managing Consultant: Regulatory Affairs, Quality, and ComplianceManagement Consultant Basic company page — company details not listed yet
Jan 2000 to Jan 2004

Education

University of Cambridge
Judge Business School - Master of Business Administration (MBA): Strategy
Cambridge Judge Business School
Judge Business School - Master of Business Administration (MBA): Strategy
Harvard University
Postdoctoral Fellow: Laboratory of Nobel Laureate Wally Gilbert, Theoretical and Computational Biology
University of California, Davis
Doctor of Philosophy (Ph.D.): Laboratory of Professor A. A. Stuchebrukhov, Theoretical and Computational Chemistry